A systematic review of economic evaluation in fecal microbiota transplantation.
Fiche publication
Date publication
janvier 2020
Journal
Infection control and hospital epidemiology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr NERICH Virginie, Dr VUITTON Lucine
Tous les auteurs :
Stalder T, Kapel N, Diaz S, Grenouillet F, Koch S, Limat S, Daval F, Vuitton L, Nerich V
Lien Pubmed
Résumé
Fecal microbiota transplantation (FMT) is an effective therapy in recurrent Clostridium difficile infection (rCDI). It is only recommended for this indication by European and American guidelines. Other indications of FMT are being studied, such as inflammatory bowel disease (IBD), and they have shown promising results.
Référence
Infect Control Hosp Epidemiol. 2020 Jan 24;:1-9